Literature DB >> 32953573

Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction.

José-María Sánchez-González1, Concepción De-Hita-Cantalejo1, María Carmen Sánchez-González1.   

Abstract

AIM: To study the effect of uncrosslinked and crosslinked hyaluronic acid combined with other artificial tear components in patients with dry eye caused by moderate meibomian gland dysfunction.
METHODS: Prospective, single-blind, contralateral eye study. Fifty eyes (25 patients) were analyzed. Eye selection for each tear type was random, and the eye drop formulations, 0.4% uncrosslinked hyaluronic acid and 0.2% galactoxyloglucan (tear A) and 0.15% crosslinked hyaluronic acid, crocin, and liposomes (tear B) were used. The determined dosing schedule was three times a day for six weeks, and the study participants underwent a clinical examination before and 45d after lubricant treatment. The Schirmer test, tear breakup time (TBUT) test, and Ocular Surface Disease Index (OSDI) questionnaire were applied before and after instillation period with both types of artificial tears.
RESULTS: On the Schirmer test, a significant improvement was obtained with both tear A (P<0.01) and tear B (P<0.01). On the TBUT test, a significant improvement was obtained with tear A (P<0.01) and tear B (P<0.01). The OSDI score significantly decreased after instillation period with both artificial tear types (P<0.01).
CONCLUSION: Uncrosslinked hyaluronic acid combined with other components, such as tamarind seed polysaccharide, and crosslinked hyaluronic acid combined with liposomes and crocin are effective for management symptoms of dry eye disease. International Journal of Ophthalmology Press.

Entities:  

Keywords:  contact lens; crosslinked hyaluronic acid; dry eye disease; liposome; meibomian gland dysfunction

Year:  2020        PMID: 32953573      PMCID: PMC7459226          DOI: 10.18240/ijo.2020.09.05

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  29 in total

Review 1.  A review of meibography.

Authors:  Heiko Pult; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2012-05       Impact factor: 1.973

Review 2.  TFOS DEWS II Introduction.

Authors:  J Daniel Nelson; Jennifer P Craig; Esen K Akpek; Dimitri T Azar; Carlos Belmonte; Anthony J Bron; Janine A Clayton; Murat Dogru; Harminder S Dua; Gary N Foulks; José A P Gomes; Katherine M Hammitt; Juha Holopainen; Lyndon Jones; Choun-Ki Joo; Zuguo Liu; Jason J Nichols; Kelly K Nichols; Gary D Novack; Virender Sangwan; Fiona Stapleton; Alan Tomlinson; Kazuo Tsubota; Mark D P Willcox; James S Wolffsohn; David A Sullivan
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

3.  Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.

Authors:  Yung Hui Kim; Yeon Soo Kang; Hyo Seok Lee; Won Choi; In Cheon You; Kyung Chul Yoon
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-28       Impact factor: 2.671

4.  Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.

Authors:  Reiko Arita; Naoyuki Morishige; Shizuka Koh; Rika Shirakawa; Motoko Kawashima; Tohru Sakimoto; Takashi Suzuki; Kazuo Tsubota
Journal:  Ophthalmology       Date:  2015-01-24       Impact factor: 12.079

5.  Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease.

Authors:  José Pinto-Fraga; Alberto López-de la Rosa; Francisco Blázquez Arauzo; Rubén Urbano Rodríguez; María J González-García
Journal:  Eye Contact Lens       Date:  2017-01       Impact factor: 2.018

6.  Clinical relationship of meibometry with ocular symptoms and tear film stability.

Authors:  Carlos García-Resúa; Hugo Pena-Verdeal; Maria Jesús Giráldez; Eva Yebra-Pimentel
Journal:  Cont Lens Anterior Eye       Date:  2017-07-23       Impact factor: 3.077

7.  Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study.

Authors:  Maurizio Rolando; Cristiana Valente
Journal:  BMC Ophthalmol       Date:  2007-03-29       Impact factor: 2.209

Review 8.  Relevance of Lipid-Based Products in the Management of Dry Eye Disease.

Authors:  Jean-Sébastien Garrigue; Mourad Amrane; Marie-Odile Faure; Juha M Holopainen; Louis Tong
Journal:  J Ocul Pharmacol Ther       Date:  2017-09-28       Impact factor: 2.671

Review 9.  Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview.

Authors:  Núria Piqué; María Del Carmen Gómez-Guillén; María Pilar Montero
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

10.  Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis.

Authors:  Dorothea Groß; Marc Childs; Jean-Marie Piaton
Journal:  Clin Ophthalmol       Date:  2017-04-06
View more
  2 in total

1.  Lipid, Aqueous and Mucin Tear Film Layer Stability and Permanence within 0.15% Liposome Crosslinked Hyaluronic Acid versus 0.15% Non-Crosslinked Hyaluronic Acid Measured with a Novel Non-Invasive Ocular Surface Analyzer.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; Concepción Martínez-Lara; María Carmen Sánchez-González
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Oral isotretinoin for acne vulgaris side effects on the ocular surface: Hyaluronic acid and galacto-xyloglucan as treatment for dry eye disease signs and symptoms.

Authors:  María Carmen Sánchez-González; Concepción De-Hita-Cantalejo; Concepción Martínez-Lara; José-María Sánchez-González
Journal:  Front Med (Lausanne)       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.